Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Mol Cancer Res. 2015 Jun 29;13(10):1431–1440. doi: 10.1158/1541-7786.MCR-14-0569

Figure 4.

Figure 4

Figure 4

Identification of a refined immunohistochemical score built against an mRNA signature of PI3K activation (Saal et al, 2007); (A) correlation between PTEN, pAKT, pS6 and stathmin and the mRNA signature of PI3K individually; and (B) distribution of 2-marker refined score using pS6 and stathmin by Gleason score.